Sign In
Buy PRVB
$24.98
+0 (+0%)
At Close: Jul 24, 2023
NEW YORK, June 2, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Provention Bio, Inc. (NASDAQ: PRVB) between November 2, 2020 and
BENSALEM, Pa.--(BUSINESS WIRE)---- $PRVB #CLASSACTION--Law Offices of Howard G. Smith reminds investors of the upcoming July 20, 2021 deadline to file a lead plaintiff motion in the case filed on beha
Los Angeles, California--(Newsfile Corp. - June 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Provention Bio, Inc.
Provention Bio Announces the Grant of Inducement Awards
07:05am, Wednesday, 02'nd Jun 2021
RED BANK, N.J., June 2, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today a
SHAREHOLDER ALERT: Robbins LLP Reminds Investors that Provention Bio, Inc. (PRVB) is Being Sued for Misleading Shareholders
12:42pm, Tuesday, 01'st Jun 2021
SAN DIEGO & RED BANK, N.J.--(BUSINESS WIRE)---- $PRVB #ClassAction--Shareholder rights law firm Robbins LLP reminds investors that a class action has been filed on behalf of all purchasers of Proventi
Los Angeles, California--(Newsfile Corp. - June 1, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Provention Bio, Inc.
Provention Bio to Present at the Jefferies Virtual Healthcare Conference
07:05am, Tuesday, 01'st Jun 2021
RED BANK, N.J., June 1, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced managem
Los Angeles, California--(Newsfile Corp. - May 31, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Provention Bio, Inc
New York, New York--(Newsfile Corp. - May 30, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pro
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Provention Bio, Inc. (NAS
New York, New York--(Newsfile Corp. - May 28, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Provention Bio, Inc. (NASDAQ:
Why Provention Bio Stock Crashed Today
04:18pm, Friday, 28'th May 2021
An FDA advisory committee vote was a lot closer than anticipated.
PRVB LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Provention Bio, Inc.
02:30pm, Friday, 28'th May 2021
New York, New York--(Newsfile Corp. - May 28, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Provention Bio, I
LOS ANGELES--(BUSINESS WIRE)---- $PRVB #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on be
New York, New York--(Newsfile Corp. - May 28, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Provention Bio, Inc. (NASDAQ: PRVB) allegin
